- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF 03882845 and Placebo
Total 42639 results
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerTerminatedHealthy VolunteersUnited States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerTerminatedType 2 Diabetic NephropathyUnited States
-
PfizerCompletedHuman VolunteersSingapore
-
PfizerRecruitingAtopic DermatitisUnited States, Canada
-
PfizerWithdrawnRespiratory Tract Diseases | Bronchial Diseases | Lung Diseases, Obstructive | Asthma, Bronchial
-
PfizerTerminated
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
PfizerRecruitingPulmonary Arterial HypertensionUnited States
-
PfizerCompletedHealthy | Chronic Rhinosinusitis With Nasal Polyps | Atopic DermatitisUnited States
-
PfizerCompletedPsoriasisCanada, United States, Japan, Poland
-
PfizerCompleted
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
PfizerCompletedAnorexia | Breast Cancer | Fatigue | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of AppetiteUnited States, Canada
-
PfizerCompleted
-
PfizerCompletedSchizophreniaUnited States
-
PfizerCompletedDiabetes Mellitus, Type 1United States
-
PfizerTerminated
-
PfizerCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedType 2 Diabetes MellitusJapan
-
PfizerCompletedCrohn's DiseaseUnited States, Spain, Lebanon, Australia, Russian Federation, Korea, Republic of, Tunisia, Italy, Poland, Belgium, Austria, Germany, Saudi Arabia, Czechia, Hungary, Switzerland, Turkey, Slovakia, Ukraine, Georgia, Bosnia and Herzegovina and more
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States, Spain, Belgium, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, France, Italy, United Kingdom, Russian Federation, Israel, Switzerland
-
PfizerCompleted
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompletedHealthy | Sickle Cell AnemiaUnited States
-
PfizerCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedCannabis DependenceUnited States
-
PfizerCompleted
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Australia, Canada, United Kingdom, Japan, Bulgaria, Italy, Poland
-
University of ZurichPfizerCompletedDecision MakingSwitzerland
-
PfizerCompleted
-
PfizerCompleted
-
BiogenCompleted
-
PfizerTerminated
-
PfizerCompleted
-
PfizerCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersBelgium
-
PfizerCompleted
-
PfizerWithdrawn
-
PfizerCompleted
-
PfizerCompletedPharmacokinetics | Safety | Phase 1 | Single Dose | TolerationBelgium
-
PfizerCompletedDiabetes Mellitus, Type IIBelgium